TSX:EXEHealthcare
Extendicare (TSX:EXE) Stock Sees Cash Flow Strength As Debt Risks Linger
Extendicare stock closed at CA$32.44 after a rough few weeks, with the share price down about 12% over the past month, yet the latest earnings tell a more supportive story. Q2 revenue landed at CA$611.0m, helped by the CBI Health acquisition and broader home care growth, while adjusted funds from operations per share climbed strongly to CA$0.448.
The short term looks choppy on the screen, but for long term investors the bigger question is whether this step change in scale and cash generation...